LiGHT trial shows more visual field progression with medication vs. laser

Secondary analysis of the LiGHT trial showed that patients treated first with medications were more likely to undergo rapid visual field progression than those treated first with selective laser trabeculoplasty.
“The LiGHT trial showed that SLT provides better clinical effectiveness and lower treatment intensity among newly diagnosed glaucoma and ocular hypertension patients compared to IOP-lowering eye drops,” David M. Wright, PhD, said at the virtual Association for Research in Vision and Ophthalmology meeting. “As for VF, no difference was found at 3 years between groups,

Full Story →